Online Impact
Statistics from Altmetric.com
ARTICLE USAGE
Cited By
Article Information
Volume 19, Issue 4, pp. 636-650
PubMed
Published By
Print ISSN
Online ISSN
History
- Received July 1, 2020
- Revision received October 28, 2020
- Accepted December 2, 2020
- Published first December 7, 2020.
Article Versions
- Previous version (December 7, 2020 - 05:41).
- Previous version (January 14, 2021 - 05:40).
- You are viewing the most recent version of this article.
Copyright & Usage
©2020 American Association for Cancer Research.
Author Information
- Kaitlyn H. Smith1,2,#,
- Amit Budhraja1,#,
- John Lynch3,
- Kathryn Roberts4,
- John C. Panetta3,
- Jon P. Connelly1,5,
- Meghan E. Turnis1,
- Shondra M. Pruett-Miller1,5,
- John D. Schuetz3,
- Charles G. Mullighan4, and
- Joseph T. Opferman1,*
- 1Department of Cell and Molecular Biology, St. Jude Children's Research Hospital, Memphis, Tennessee.
- 2Integrated Program in Biomedical Sciences, University of Tennessee Health Science Center, Memphis, Tennessee.
- 3Department of Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, Tennessee.
- 4Department of Pathology, St. Jude Children's Research Hospital, Memphis, Tennessee.
- 5Center for Advanced Genome Engineering, St. Jude Children's Research Hospital, Memphis, Tennessee.
- ↵*Corresponding Author:
Joseph T. Opferman, St. Jude Children's Research Hospital, 262 Danny Thomas Place, D-4007C, Memphis, TN 38105. Phone: 901-595-5524; Fax: 901-525-8025; E-mail: Joseph.Opferman{at}stjude.org
↵#K.H. Smith and A. Budhraja contributed equally to this article.
April 2021
Volume 19, Issue 4
Volume 19, Issue 4
The Heme-Regulated Inhibitor Pathway Modulates Susceptibility of Poor Prognosis B-Lineage Acute Leukemia to BH3-Mimetics
Jump to section
Advertisement